William R. Drummond Jr., BSc, MBA, CQA, is a global scientific and engineering leader specializing in biomaterials, polymer science, biocompatibility, toxicology, and medical device product development. With more than 20 years of experience, he has supported the development, biological evaluation, risk assessment, and regulatory approval of medical devices, biomaterials, and combination products for commercialization across the United States, Europe, Canada, Japan, China, South Korea, and Brazil.
William has held scientific and leadership positions with Mammotome (Danaher), Abbott Cardiovascular, Zimmer Biomet, Natus Medical, Johnson & Johnson Vision, Pall Life Sciences, and Monsanto. He is recognized for transforming complex scientific and regulatory challenges into practical patient-safety solutions by integrating biomaterials science, toxicology, engineering, quality systems, and regulatory strategy.
He holds a Bachelor of Science in Biology from the University of South Alabama, an MBA from the University of West Florida, and is a Certified Quality Auditor (CQA). He has been recognized by Marquis Who’s Who for contributions to Biomedical Devices and Biotechnology.